Biotechnology Archives

Conceptual Serina Therapeutics laboratory illustration with neurons, drug-delivery imagery and a display highlighting a potential 2027 clinical milestone.

Serina Therapeutics: A Parkinson’s Bet Where Delivery Is the Message -( $ABBV $SER )

by John F. Heerdink, Jr. 4 days ago 124Views 0Likes

As SER-252 advances into its second dose cohort, Serina is building a case that improving how a medicine reaches patients can be as consequential as discovering the medicine itself. Serina Therapeutics, Inc. (NYSE American: SER) is pursuing an appealing proposition in biotechnology:…

I drug discovery display with molecular structures on a skyscraper near Wall Street, above green market graphics and overlooking business professionals at dusk

Iambic’s $150 Million IPO Puts AI Drug Discovery in Wall Street’s Spotlight -( $IAM $IBB $JNJ $LLY $NVDA $TAK $XBI )

by John F. Heerdink, Jr. October 12, 2026 775Views 0Likes

Nvidia-backed biotech pairs a clinical-stage cancer pipeline with pharmaceutical partnerships as TRex Bio, Retension and Lycia join the IPO queue October 8, 2026 Artificial intelligence has spent the past several years promising to transform drug discovery. Iambic Therapeutics is now asking Wall…

Conceptual illustration of robotic arms automating drug manufacturing, with a giant glass vessel pouring into bioreactors against the San Francisco skyline.

Multiply Labs Raises $75 Million as Physical AI Takes Aim at Biotech’s Manufacturing Bottleneck -( $AZN $KYTX $LEGN $NVS $TER )

by John F. Heerdink, Jr. October 11, 2026 791Views 0Likes

Backed by AstraZeneca and Teradyne, the robotics company is betting that the next breakthrough in medicine will need a breakthrough on the factory floor. Artificial intelligence can help design a promising medicine. It cannot deliver a dose by admiring its own calculations.…

Trading floor illustration with traders at monitors beneath signs reading “Nasdaq Falls,” “Oil Prices Rise” and “Rate Worries.”

Stock Market Today, October 8, 2026: Nasdaq Falls 1.25% as Oil and Rate Worries Weigh on Wall Street -( $AMZN $DOCS EPRX $ERAS $GS $HPP $MODD $NVDA $PLTR $SER $SOC $SPCX $T $YSG )

by John F. Heerdink, Jr. October 8, 2026 153520Views 0Likes

NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.

Comic-style illustration of Michael J. Fox pointing toward Parkinson’s research and clinical trial displays, surrounded by scientists, patients and investors, with upward arrows symbolizing progress and investor optimism.

The Michael J. Fox Foundation Is Building Parkinson’s Next Chapter. Investors Have Reason to Pay Attention. -( $ABBV $IBB $SER $XBI )

by John F. Heerdink, Jr. October 8, 2026 467Views 0Likes

Better biomarkers, new FDA approvals and an emerging delivery pipeline strengthen the case for Parkinson’s innovation, with AbbVie and Serina Therapeutics offering distinct investment angles. The most compelling Parkinson’s investment story does not begin with a stock chart. It begins with a…

Tag: Biotechnology

Serina Therapeutics: A Parkinson’s Bet Where Delivery Is the Message -( $ABBV $SER )

Iambic’s $150 Million IPO Puts AI Drug Discovery in Wall Street’s Spotlight -( $IAM $IBB $JNJ $LLY $NVDA $TAK $XBI )

Multiply Labs Raises $75 Million as Physical AI Takes Aim at Biotech’s Manufacturing Bottleneck -( $AZN $KYTX $LEGN $NVS $TER )

Stock Market Today, October 8, 2026: Nasdaq Falls 1.25% as Oil and Rate Worries Weigh on Wall Street -( $AMZN $DOCS EPRX $ERAS $GS $HPP $MODD $NVDA $PLTR $SER $SOC $SPCX $T $YSG )

The Michael J. Fox Foundation Is Building Parkinson’s Next Chapter. Investors Have Reason to Pay Attention. -( $ABBV $IBB $SER $XBI )

Your Guide To Staying Informed In The Markets